Zang, Shufei <br/><br/>
Haptoglobin Genotype and Vitamin E Versus Placebo for the Treatment of Nondiabetic Patients with Nonalcoholic Steatohepatitis in China: A Multicenter, Randomized, Placebo-Controlled Trial Design.  [electronic resource] 

 -  Advances in therapy  02 2018 
 - 218-231 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1865-8652 
<br/><br/><label>Standard No.: </label>10.1007/s12325-018-0670-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Body Weights and Measures<br/>China<br/>Cytokines--drug effects<br/>Double-Blind Method<br/>Elasticity Imaging Techniques<br/>Genotype<br/>Haptoglobins--genetics<br/>Humans<br/>Inflammation--drug therapy<br/>Life Style<br/>Mobile Applications<br/>Non-alcoholic Fatty Liver Disease--drug therapy<br/>Quality of Life<br/>Research Design<br/>Severity of Illness Index<br/>Vitamin E--therapeutic use